Valdecoxib Recovers the Lipid Composition Order and Dynamics in Colon Cancer Cell Lines Independent of COX 2 Expression An ATR FTIR Spectroscopy Study
 
Yazarlar (4)
Arş. Gör. Dr. Aysun İNAN GENÇ Kastamonu Üniversitesi, Türkiye
Seher Gök Bilecik Şeyh Edebali Üniversitesi, Türkiye
Sreeparna Banerjee Orta Doğu Teknik Üniversitesi, Türkiye
Feride Severcan İstanbul Kemerburgaz Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Applied Spectroscopy (Q1)
Dergi ISSN 0003-7028 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 01-2017
Kabul Tarihi Yayınlanma Tarihi 20-07-2016
Cilt / Sayı / Sayfa 71 / 1 / 105–117 DOI 10.1177/0003702816654164
Makale Linki http://asp.sagepub.com/lookup/doi/10.1177/0003702816654164
Özet
Prostanoids play an important role in a variety of physiological and pathophysiological processes including inflammation and cancer. The rate-limiting step in the prostanoid biosynthesis pathway is catalyzed by cyclooxygenases (COXs). Aberrant expression of the inducible isoform COX-2 plays a significant role in colon cancer initiation and progression. In this study, we have hypothesized that COX-2 specific inhibitors such as Valdecoxib (VLX), being highly hydrophobic, may alter biophysical properties of cellular lipids. In this study, COX-2 expressing (HT29) and COX-2 non-expressing (SW620) colon cancer cell lines were treated with VLX and examined using attenuated total reflection infrared spectroscopy. The results revealed that VLX treatment decreased lipid fluidity in the cells irrespective of COX-2 expression status and affected order parameters of the lipids in both cell lines. Cluster analysis also indicated …
Anahtar Kelimeler
ATR-FT-IR spectroscopy | attenuated total reflection infrared spectroscopy | Colon cancer | COX-2 inhibitors | HT29 | SW620 | valdecoxib